Literature DB >> 9193182

Surgical management of primary cutaneous melanomas of the hands and feet.

J F Tseng1, K K Tanabe, M A Gadd, A B Cosimi, R A Malt, F G Haluska, M C Mihm, A J Sober, W W Souba.   

Abstract

OBJECTIVE: The purpose of the study was to investigate the surgical management of cutaneous melanomas of the hands and feet. SUMMARY BACKGROUND DATA: Prior studies suggest that patients with melanomes > 1-mm thick should be treated with excision with a 2-cm margin and undergo elective lymphadenectomy in selected circumstances. These recommendations are based primarily on data from melanomas of the trunk and extremities. Melanomas of the hands and feet are less common and less well studied. They pose a surgical challenge because primary wound closure often is difficult, and the incidence and management of regional node metastases are unclear.
METHODS: Charts of patients with melanomas of the hands or feet treated at the Massachusetts General Hospital between 1980 and 1994 were reviewed retrospectively. Local recurrence rates and the incidence of regional node metastases were analyzed as a function of histology, margin of excision, and microscopic thickness of the melanoma.
RESULTS: Data from 116 patients (39 men, 77 women) with melanomas of the hands (n = 26) and feet (n = 90) were evaluated. Pathologic diagnoses were: acral lentiginous melanoma (48 patients); subungual melanoma (13 patients), and skin of dorsum of the hand or foot (n = 55). Digital amputation was required in all 13 patients with subungual melanoma to maintain local control; still, nodal metastases developed in 46% of patients within 1 year. Seventy-one percent of patients with acral lentiginous melanoma presented with lesions > or = 1.5 mm, and nodes or systemic disease or both developed in 56% of patients. Acral lentiginous melanoma lesions < 1.5-mm thick were treated principally by excision with a 1-cm margin; a local recurrence or metastases did not develop in any of the patients. None of the patients with melanomas on the dorsum of the hand or foot < 1.5-mm thick had a local recurrence, but regional or systemic disease developed in > 50%. Local control in patients with lesions > 1.5-mm thick frequently required skin grafting or amputation. The majority of patients with melanomas > or = 1.5 mm in thickness undergoing elective lymph node dissection had histologically positive nodes for melanoma.
CONCLUSIONS: Melanomas of the hands and feet < 1.5-mm thick have a low incidence of nodal metastases and are treated effectively with wide excision of the primary with a 1-cm margin. Thicker melanomas are associated with a > 50% rate of regional or systemic failure. In the absence of metastatic disease, these individuals should undergo local excision with a 2-cm margin and intraoperative lymphatic mapping followed by lymphadenectomy if the sentinel node is positive.

Entities:  

Mesh:

Year:  1997        PMID: 9193182      PMCID: PMC1190793          DOI: 10.1097/00000658-199705000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

Review 1.  A factual, not arbitrary, basis for choice of resection margins in melanoma.

Authors:  M Piepkorn; R L Barnhill
Journal:  Arch Dermatol       Date:  1996-07

2.  Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.

Authors:  U Veronesi; N Cascinelli; J Adamus; C Balch; D Bandiera; A Barchuk; R Bufalino; P Craig; J De Marsillac; J C Durand
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

3.  Local failure in the treatment of melanoma. The Janeway lecture, 1966.

Authors:  G McNeer; J Cantin
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1967-04

4.  Malignant melanoma of the hand and foot: diagnosis and management.

Authors:  L E Hughes; K Horgan; B A Taylor; P Laidler
Journal:  Br J Surg       Date:  1985-10       Impact factor: 6.939

5.  Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.

Authors:  C M Balch; S J Soong; A A Bartolucci; M M Urist; C P Karakousis; T J Smith; W J Temple; M I Ross; W R Jewell; M C Mihm; R L Barnhill; H J Wanebo
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

Review 6.  The role of elective lymph node dissection in melanoma: rationale, results, and controversies.

Authors:  C M Balch
Journal:  J Clin Oncol       Date:  1988-01       Impact factor: 44.544

7.  Surgical management and prognostic factors in patients with subungual melanoma.

Authors:  K M Heaton; A el-Naggar; L G Ensign; M I Ross; C M Balch
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

8.  Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients.

Authors:  C L Slingluff; K R Stidham; W M Ricci; W E Stanley; H F Seigler
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

9.  Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.

Authors:  C M Balch; M M Urist; C P Karakousis; T J Smith; W J Temple; K Drzewiecki; W R Jewell; A A Bartolucci; M C Mihm; R Barnhill
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

10.  A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease.

Authors:  C L Day; A J Sober; A W Kopf; R A Lew; M C Mihm; F M Golomb; P Hennessey; M N Harris; S L Gumport; J W Raker; R A Malt; A B Cosimi; W C Wood; D F Roses; F Gorstein; T B Fitzpatrick; A Postel
Journal:  Surgery       Date:  1981-05       Impact factor: 3.982

View more
  6 in total

1.  Clinical features of malignant melanoma of the finger and therapeutic efficacies of different treatments.

Authors:  Zuozhang Yang; Lin Xie; Yunchao Huang; Hongpu Sun; Tao Yuan; Xiang Ma; Congguo Jing; Pengjie Liu
Journal:  Oncol Lett       Date:  2011-06-10       Impact factor: 2.967

2.  Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick.

Authors:  J Gregory McKinnon; Emma C Starritt; Richard A Scolyer; William H McCarthy; John F Thompson
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

3.  Treatment and outcomes of melanoma in acral location in Korean patients.

Authors:  Mi Ryung Roh; Jihyun Kim; Kee Yang Chung
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

4.  Quinacrine for extremity melanoma in a mouse model of isolated limb perfusion (ILP).

Authors:  Minhyung Kim; Asher B Blum; Michelle L Haslinger; Michael J Donahue; Daniel T Fisher; Joseph J Skitzki; Il Young Park
Journal:  Surg Today       Date:  2014-07-08       Impact factor: 2.549

5.  Prognostic variables and surgical management of foot melanoma: review of a 25-year institutional experience.

Authors:  Omar M Rashid; Julia C Schaum; Luke G Wolfe; Nooshin K Brinster; James P Neifeld
Journal:  ISRN Dermatol       Date:  2011-07-26

6.  Two-team-approached free flap reconstruction for plantar malignant melanoma: An observational (STROBE-compliant) trial.

Authors:  Jun Hyeok Kim; Chae Rim Lee; Hyo Jeong Kwon; Deuk Young Oh; Young-Joon Jun; Jong Won Rhie; Suk-Ho Moon
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.